Treatment approaches in Gilles de la Tourette syndrome.

Abstract

The neurological disorder Gilles de la Tourette syndrome is most often treated with the receptor blocker haloperidol, which also produces multiple side-effects, including the risk for tardive dyskinesia. In placebo control double-blind studies, two other neuroleptic drugs, fluphenazine and trifluoperazine, were found to be as efficaceous as haloperidol, but… (More)

Topics

Cite this paper

@article{Borison1983TreatmentAI, title={Treatment approaches in Gilles de la Tourette syndrome.}, author={Richard L. Borison and L. K. Ang and William J. Hamilton and Bob Diamond and J. M. Davis}, journal={Brain research bulletin}, year={1983}, volume={11 2}, pages={205-8} }